Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer

Proteomics - Clinical Applications

Volumn 5, Issue 3-4, 2011, Pages 179-188

  Schoenherr, Regine M ^a   Kelly Spratt, Karen S ^a   Lin, Chenwei ^a   Whiteaker, Jeffrey R ^a   Liu, Tao ^b   Holzman, Ted ^a   Coleman, Ilsa ^a   Feng, Li Chia ^a   Lorentzen, Travis D ^a   Krasnoselsky, Alexei L ^a   Wang, Pei ^a   Liu, Yan ^a   Gurley, Kay E ^a   Amon, Lynn M ^a   Schepmoes, Athena A ^b   Moore, Ronald J ^b   Camp Ii, David G ^b   Chodosh, Lewis A ^c   Smith, Richard D ^b   Nelson, Peter S ^a   Mcintosh, Martin W ^a   Kemp, Christopher J ^a   Paulovich, Amanda G ^a   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Her2; Mouse; Proteome; Transcriptome

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEOME; TRANSCRIPTOME;

ACCESS TO INFORMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER RESEARCH; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUALITY CONTROL; REFERENCE DATABASE; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

ANIMALS; BREAST NEOPLASMS; DATABASES, PROTEIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; MICE; MICE, TRANSGENIC; PROTEOME; PROTEOMICS; RECEPTOR, ERBB-2; TANDEM MASS SPECTROMETRY; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 79953081641     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000037     Document Type: Article

References (35)

1. Quaglino, E., Mastini, C., Forni, G., Cavallo, F., ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. Curr. Protoc. Immunol. 2008, Chapter 20, Unit 20.9.1-20.9-10.
2. Bouwman, P., Jonkers, J., Mouse models for BRCA1 associated tumorigenesis: from fundamental insights to preclinical utility. Cell Cycle 2008, 7, 2647-2653.
3. Frese, K. K., Tuveson, D. A., Maximizing mouse cancer models. Nat. Rev. Cancer 2007, 7, 645-658.
4. Vargo-Gogola, T., Rosen, J. M., Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 2007, 7, 659-672.
5. Whiteaker, J. R., Zhang, H., Zhao, L., Wang, P. et al., Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J. Proteome Res. 2007, 6, 3962-3975.
6. Moody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J. et al., Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2002, 2, 451-461.
7. Rodriguez, H., Snyder, M., Uhlen, M., Andrews, P. et al., Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J. Proteome Res. 2009, 8, 3689-3692.
8. Kelly-Spratt, K. S., Kasarda, A. E., Igra, M., Kemp, C. J., A mouse model repository for cancer biomarker discovery. J. Proteome Res. 2008, 7, 3613-3618.
9. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. et al., Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
10. Xu, H., Freitas, M. A., Automated diagnosis of LC-MS/MS performance. Bioinformatics 2009, 25, 1341-1343.
11. Mirzaei, H., Brusniak, M. Y., Mueller, L. N., Letarte, S. et al., Halogenated peptides as internal standards (H-PINS): introduction of an MS-based internal standard set for liquid chromatography-mass spectrometry. Mol. Cell. Proteomics 2009, 8, 1934-1946.
12. Tabb, D. L., Vega-Montoto, L., Rudnick, P. A., Variyath, A. M. et al., Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2010, 9, 761-776.
13. Paulovich, A. G., Billheimer, D., Ham, A. J., Vega-Montoto, L. et al., Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol. Cell. Proteomics 2010, 9, 242-254.
14. Rudnick, P. A., Clauser, K. R., Kilpatrick, L. E., Tchekhovskoi, D. V. et al., Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol. Cell. Proteomics 2010, 9, 225-241.
15. Kuhn, E., Wu, J., Karl, J., Liao, H. et al., Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
16. Keshishian, H., Addona, T., Burgess, M., Mani, D. R. et al., Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2009, 8, 2339-2349.
17. Kline, K. G., Frewen, B., Bristow, M. R., MacCoss, M. J., Wu, C. C., High quality catalog of proteotypic peptides from human heart. J. Proteome Res. 2008, 7, 5055-5061.
18. Liu, T., Qian, W. J., Strittmatter, E. F., Camp, D. G., 2nd et al., High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal. Chem. 2004, 76, 5345-5353.
19. Liu, T., Qian, W. J., Chen, W. N., Jacobs, J. M. et al., Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: the human mammary epithelial cell proteome. Proteomics 2005, 5, 1263-1273.
20. Bellew, M., Coram, M., Fitzgibbon, M., Igra, M. et al., A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics 2006, 22, 1902-1909.
21. Livesay, E. A., Tang, K., Taylor, B. K., Buschbach, M. A. et al., Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal. Chem. 2008, 80, 294-302.
22. Liu, H., Sadygov, R. G., Yates, J. R., 3rd, A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
23. Ishihama, Y., Oda, Y., Tabata, T., Sato, T. et al., Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 2005, 4, 1265-1272.
24. Craig, R., Beavis, R. C., A method for reducing the time required to match protein sequences with tandem mass spectra. Rapid Commun. Mass Spectrom. 2003, 17, 2310-2316.
25. Craig, R., Beavis, R. C., TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20, 1466-1467.
26. MacLean, B., Eng, J. K., Beavis, R. C., McIntosh, M., General framework for developing and evaluating database scoring algorithms using the TANDEM search engine. Bioinformatics 2006, 22, 2830-2832.
27. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
28. Rauch, A., Bellew, M., Eng, J., Fitzgibbon, M. et al., Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J. Proteome Res. 2006, 5, 112-121.
29. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
30. Petyuk, V. A., Qian, W. J., Hinault, C., Gritsenko, M. A. et al., Characterization of the mouse pancreatic islet proteome and comparative analysis with other mouse tissues. J. Proteome Res. 2008, 7, 3114-3126.
31. Zhang, X., Zhou, J. Y., Chin, M. H., Schepmoes, A. A. et al., Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model. J. Proteome Res. 2010, 9, 1496-1509.
32. True, L., Coleman, I., Hawley, S., Huang, C. Y. et al., A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc. Natl. Acad. Sci. USA 2006, 103, 10991-10996.
33. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R. et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
34. Menon, R., Omenn, G. S., Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers. Cancer Res. 2010, 70, 3440-3449.
35. Yang, X., Lazar, I. M., MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides. BMC Cancer 2009, 9, 96.